AmiA is a penicillin target enzyme with dual activity in the intracellular pathogen Chlamydia pneumoniae
Citations Over TimeTop 10% of 2014 papers
Abstract
Intracellular Chlamydiaceae do not need to resist osmotic challenges and a functional cell wall was not detected in these pathogens. Nevertheless, a recent study revealed evidence for circular peptidoglycan-like structures in Chlamydiaceae and penicillin inhibits cytokinesis, a phenomenon known as the chlamydial anomaly. Here, by characterizing a cell wall precursor-processing enzyme, we provide insights into the mechanisms underlying this mystery. We show that AmiA from Chlamydia pneumoniae separates daughter cells in an Escherichia coli amidase mutant. Contrary to homologues from free-living bacteria, chlamydial AmiA uses lipid II as a substrate and has dual activity, acting as an amidase and a carboxypeptidase. The latter function is penicillin sensitive and assigned to a penicillin-binding protein motif. Consistent with the lack of a regulatory domain in AmiA, chlamydial CPn0902, annotated as NlpD, is a carboxypeptidase, rather than an amidase activator, which is the case for E. coli NlpD. Functional conservation of AmiA implicates a role in cytokinesis and host response modulation.
Related Papers
- → The Elusive but Pathogenic Peptidoglycan of Chlamydiae(2013)6 cited
- Inflammatory properties of peptidoglycan are decreased after degradation by human N-acetylmuramyl-L-alanine amidase.(1997)
- → French situation concerning the Swedish Chlamydia trachomatis variant(2007)24 cited
- → N-Acetylmuramoyl-l-alanine amidase(2004)4 cited
- → Pljučnica pri dojenčku, povzročena z bakterijo Chlamydiae trachomatis(2016)